InsidersTradesSigma
Track the Corline Biomedical AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Corline Biomedical AB has logged 1 insider filings. Market capitalisation: €458.6m. The latest transaction was filed on 18 November 2025 (Purchase). Among the most active insiders: Henrik Nittmar. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Corline Biomedical AB is a company focused on the development of biopharmaceutical products. It concentrates on innovative solutions for the treatment of serious diseases.